Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1996-05-08
1998-12-15
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424 932, 4241841, A01J 2100, A01J 2512, A21C 300, A21C 1100
Patent
active
058493050
ABSTRACT:
Methylation of DNA can be a critical step in the introduction of DNA into P. haemolytica. A methyltransferase has been isolated and molecularly cloned for this purpose. Use of the methyltransferase has allowed construction of defined, attenuated mutants for use as vaccines to protect cattle.
REFERENCES:
patent: 4293545 (1981-10-01), Kucera
patent: 4335106 (1982-06-01), Kucera
patent: 4346074 (1982-08-01), Gilmour et al.
patent: 4388299 (1983-06-01), Kucera
patent: 4506017 (1985-03-01), Kucera
patent: 4559306 (1985-12-01), Kucera
patent: 4626430 (1986-12-01), Kucera
patent: 4735801 (1988-04-01), Stocker et al.
patent: 4837151 (1989-06-01), Stocker et al.
patent: 4888170 (1989-12-01), Curtiss
patent: 4957739 (1990-09-01), Berget et al.
patent: 4999191 (1991-03-01), Glisson et al.
patent: 5055400 (1991-10-01), Lo et al.
patent: 5077044 (1991-12-01), Stocker et al.
patent: 5165924 (1992-11-01), Shewen et al.
patent: 5210035 (1993-05-01), Stocker
patent: 5238823 (1993-08-01), Potter et al.
patent: 5273889 (1993-12-01), Potter et al.
patent: 5389368 (1995-02-01), Curtiss, III
patent: 5424065 (1995-06-01), Curtiss, III
patent: 5468485 (1995-11-01), Curtiss, III
patent: 5476657 (1995-12-01), Potter
patent: 5543312 (1996-08-01), Mellors et al.
Homchampa et al., "Molecular Analysis of the aroA Gene of Pasteurella Multocida and Vaccine Potential of a Constructed aroA Mutant," Molecular Microbiology, 6(23):3585-3593 (1992).
Lindberg et al, Dev. Biol Stand., 1995, vol. 84, pp. 211-219.
Chang et al., "Pneumonic pasteurellosis: Examination of typable and untypable Pasteurella haemolytica strains for Leukotoxin Production, Plasmic Content, and Antimicrobial Susceptibility," Am. J. Vet. Res., 48(3):378-384 (1987).
Briggs et al., "Isolation of a Cryptic Plasmic from Pasteurella haemolytica b Electroporation," Abstract, 72nd Annual Meeting of the Conference of Research Workers in Animal Disease, Nov. 11, 1991.
Livrelli et al., "Sequence and Molecular Characterization of the ROB-1 .beta.-Lactamase Gene from Pasteurella Haemolytica," Antimicrobial Agents and Chemotherapy, 35(2):242-251 (1991).
Rickets et al., "Leukotoxin and Pathogenicity of Pasteurella Haemolytica: Studies with a Leukotoxin Non-Producing Mutant", Abstract, 3rd International Veterinary Symposium, PS 7.19, p. 92 (1993).
Frey, "Construction of a Broad Host Range Shuttle Vector for Gene Cloning and Expression in Actinobacillus pleuropneumoniae and Other Pasteurellaceae," Res. Microbiol. 143:263-269 (1992).
Craig et al., "A Plasmic Which Can Be Transferred Between Eschirichia coli and Pasteurella haemolytica by Electroporation and Conjugation," J. Gen. Microbiology, 135:2885-2890 (1989).
Boyce et al., "Plasmid Profile Analysis of Bovine Isolates of Pasteurella haemolytica," Am. J. Vet. Res. 47(6):1204-1206 (1986).
Schwarz, et al., "Detection and Interspecies-Transformation of a .beta.-Lactamase-Encoding Plasmid from Pasteurella haemolytica," Zbl. Bakt. Hyg. A, 270462-469 (1989).
Haghour et al., "Plasmids and Resistance to 9 Chemotherapeutic Agents of Pasteurella multocida and Pasteurella haemolytica," J. Vet. Med. B 34:509-518 (1987).
Azad et al., "Distinct Plasmic Profiles of Pasteurella haemolytica Serotypes and the Characterization and Amplification of Escherichia coli of Ampicillin-Resistance Plasmids Encoding ROB-1 .beta.-lactamase," J. Gen. Microbiology, 138:1185-1196 (1992).
Hoiseth et al., "Aromatic-dependent Salmonella typhimurium are Non-Virulent and Effective as Live Vaccines," Nature, 291:238-239 (1981).
Smith et al., "Vaccination of Calvea Against Salmonella dublin With Aromatic-Dependent Salmonella typhimurium," Am. J. Vet. Res., 45(9):1858 (1984).
Roberts et al., "Construction and Characterization in vivo of Bordetella pertussis aroA Mutants," Infection and Immunity 58(3):732-738 (1990).
Ivins et al., "Immunization against Anthrax With Aromatic Compound-Dependent (Aro) Mutants of Bacillus anthracis and with Recombinant Strains of Bacillus subtilis That Produce Anthrax Protective Antigen," Infection and Immunity, 58(2):303-308 (1990).
Robertsson et al., "Salmonella typhimurium Infection in Calves; Protection and Survival of Virulent Challenge Bacteria After Immunization with Live or Inactivated Vaccines," Infection and Immunity 41(2):742-750 (1983).
O'Gaora et al., "Cloning and Characterization of the serC and aro A Genes of Yersinia enterocolitica, and Construction of an aroA mutant," Gene 84:23-30 (1989).
Chang et al., "Characterization of Plasmids With Antimicrobial Resistant Genes in Pasteurella haemolytica A1," J. DNA Sequencing and Mapping, 389-97 (1992).
Rossmanith et al., "Characterization and Comparison of Antimicrobial Susceptibilities and Outer Membrane Protein and Plasmic DNA profiles of Pasteurella haemolytica and Certain Other Members of the Genus Pasteurella," Am. J. Vet. Res., 52(12):2016-2022 (1991).
Tatum et al., "Isolation, Identification, and Cloning of a Non-Palindromic Type II DNA Restriction Endonuclease Pha I, From Pasteurella haemolytica", Abstract of presentation at American Society for Microbiology, Annual Meeting, May 1993.
Yang et al., J. Bact., 160(i); 15-21 (1984).
Matsushima et al., J. Bact., 169(5):2298-2300 (1987).
Marmelstein et al., Appl. Environ. Micro., (59/4): 1077-1081 (1993).
Wilson, Gene 74: 281-289 (1988).
Marra et al., J. Bact., 171/4:2238-2240 (1989).
Briggs et al., "Characterization of a Restriction Endonuclease, PhaI, from Pasteuirella haemolytica Serotype A1 and Protection of Heterologous DNA by a Cloned Pha1 Methyltransferase Gene", Applied and Environmental Microbiology 60(6):2006-2010 (1994).
Tatum et al., "Molecular Gene Cloning and Nucleotide Sequencing and Construction of an aroA Mutant of Pasteurella haemolytica Serotype A1", Applied and Environmental Microbiology 60(6):2011-2016 (1994).
Old, et al., "Principles of Gene Manipulation", Blackwell Scientific Publications, Oxford, 1989.
Lunnen et al., "Cloning Type-II Restriction and Modification Genes", Gene 74:25-32 (1988).
Homchampa et al., "Construction and Vaccine Potential of an ArcA Mutant of Pasteurella haemolytica", Veterinary Microbiology 42:35-44 (1994).
Briggs Robert E.
Tatum Fred M.
Biotechnology Research And Development Corporation
Housel James C.
Portner Ginny Allen
The United States of America as represented by the Secretary of
LandOfFree
Construction of Pasteurella haemolytica vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Construction of Pasteurella haemolytica vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Construction of Pasteurella haemolytica vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455247